Literature DB >> 11834839

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.

T R Gadek1, D J Burdick, R S McDowell, M S Stanley, J C Marsters, K J Paris, D A Oare, M E Reynolds, C Ladner, K A Zioncheck, W P Lee, P Gribling, M S Dennis, N J Skelton, D B Tumas, K R Clark, S M Keating, M H Beresini, J W Tilley, L G Presta, S C Bodary.   

Abstract

The protein-protein interaction between leukocyte functional antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is critical to lymphocyte and immune system function. Here, we report on the transfer of the contiguous, nonlinear epitope of ICAM-1, responsible for its association with LFA-1, to a small-molecule framework. These LFA-1 antagonists bound LFA-1, blocked binding of ICAM-1, and inhibited a mixed lymphocyte reaction (MLR) with potency significantly greater than that of cyclosporine A. Furthermore, in comparison to an antibody to LFA-1, they exhibited significant anti-inflammatory effects in vivo. These results demonstrate the utility of small-molecule mimics of nonlinear protein epitopes and the protein epitopes themselves as leads in the identification of novel pharmaceutical agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834839     DOI: 10.1126/science.295.5557.1086

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

Review 1.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

Review 2.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

3.  A small molecule agonist of an integrin, alphaLbeta2.

Authors:  Wei Yang; Christopher V Carman; Minsoo Kim; Azucena Salas; Motomu Shimaoka; Timothy A Springer
Journal:  J Biol Chem       Date:  2006-10-05       Impact factor: 5.157

4.  Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1.

Authors:  Matthias Dormeyer; Yvonne Adams; Bernd Kramer; Srabasti Chakravorty; Man Tsuey Tse; Stefano Pegoraro; Lisa Whittaker; Michael Lanzer; Alister Craig
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.

Authors:  Yang Wang; Dan Li; Roza Nurieva; Justin Yang; Mehmet Sen; Roberto Carreño; Sijie Lu; Bradley W McIntyre; Jeffrey J Molldrem; Glen B Legge; Qing Ma
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

Review 6.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

7.  Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).

Authors:  Vidhya R Rao; Elizabeth Prescott; Namdev B Shelke; Ruchit Trivedi; Peter Thomas; Craig Struble; Tom Gadek; Charles A O'Neill; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

8.  Regulation of integrin affinity on cell surfaces.

Authors:  Thomas Schürpf; Timothy A Springer
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

9.  Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.

Authors:  Sarath Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-20       Impact factor: 2.671

10.  Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease.

Authors:  Christopher G Kevil; M John Hicks; Xiaodong He; Junxuan Zhang; Christie M Ballantyne; Chander Raman; Trenton R Schoeb; Daniel C Bullard
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.